The trial of 40 adults with 2 dose levels found the vaccine safe and immunogenic.
In one case, relying on ultrasound alone would have given the mother false assurance.
Neutralizing monoclonal antibodies engineered from three humans infected with Zika virus protected non-human primates from contracting the mosquito-borne disease, according to a new study published in Science Translational Medicine.
After a lag in reporting last week, the Saudi Arabian Ministry of Health (MOH) updated it information on MERS-CoV cases over the weekend, noting three new cases since the agency last reported on Sep 25.
One genetic mutation in 2013 allowed the virus to become more infective and cause birth defects, a new study suggests.
The antibody protected both adult and fetal mice against Zika infection.
A single dose of the live-attenuated vaccine prevents transmission to the offspring of pregnant mice, as well as preventing testicular damage in male mice.
About 75% of counties on the US mainland have suitable habitat for Aedes mosquitoes, CDC researchers say.
EpiVax, Inc., a vaccine development and immune engineering company based in Providence, R.I., yesterday announced it is part of collaboration supported by a $5.8 million award from the National Institutes of Health (NIH) to develop a new type of vaccine against H7N9 avian influenza.
Italy has now confirmed 14 cases of locally acquired chikungunya, 6 of them in Rome, the World Health Organization (WHO) said in a Sep 15 statement.
